Cargando…
Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy
AIMS: Immunoadsorption with subsequent immunoglobulin G substitution (IA/IgG) represents a novel therapeutic approach in the treatment of dilated cardiomyopathy (DCM) which leads to the improvement of left ventricular ejection fraction (LVEF). However, response to this therapeutic intervention shows...
Autores principales: | Ameling, Sabine, Herda, Lars R., Hammer, Elke, Steil, Leif, Teumer, Alexander, Trimpert, Christiane, Dörr, Marcus, Kroemer, Heyo K., Klingel, Karin, Kandolf, Reinhard, Völker, Uwe, Felix, Stephan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584995/ https://www.ncbi.nlm.nih.gov/pubmed/23100283 http://dx.doi.org/10.1093/eurheartj/ehs330 |
Ejemplares similares
-
Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2016) -
Erratum to: Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2017) -
Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009) -
Proteomic analyses of age related changes in A.BY/SnJ mouse hearts
por: Nishtala, Krishnatej, et al.
Publicado: (2013) -
Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)